<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>4</IssueIDStart>
          <IssueIDEnd>4</IssueIDEnd>
          <IssueArticleCount>15</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>12</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2006</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art12">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>74895</ArticleID>
            <ArticleDOI>10.1208/aapsj070487</ArticleDOI>
            <ArticleSequenceNumber>12</ArticleSequenceNumber>
            <ArticleTitle Language="En">Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia</ArticleTitle>
            <ArticleFirstPage>E895</ArticleFirstPage>
            <ArticleLastPage>E902</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2004</Year>
                <Month>11</Month>
                <Day>24</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>12</Month>
                <Day>5</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>4</IssueIDStart>
              <IssueIDEnd>4</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Feng</GivenName>
                  <FamilyName>Jin</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Zia</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Tayab</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Joseph</GivenName>
                  <GivenName>P.</GivenName>
                  <FamilyName>Balthasar</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>716-645-2842</Phone>
                  <Fax>716-645-3693</Fax>
                  <Email>jb@buffalo.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo</OrgDivision>
                <OrgName>State University of New York</OrgName>
                <OrgAddress>
                  <Postcode>14260</Postcode>
                  <City>Buffalo</City>
                  <State>NY</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Intravenous administration of pooled, polyvalent human immunoglobulin (IVIG) has been used for over 20 years as a therapy for immune thrombocytopenia (ITP). IVIG is available in limited quantities, and clinical preparations have been associated with the transfer of human pathogens. We have proposed that high-dose monoclonal antibody may be used in lieu of IVIG to achieve beneficial effects in the treatment of ITP. The current study investigates the effects of high-dose monoclonal antibody therapy in a rat model of ITP. Hybridoma cells secreting a murine monoclonal antiplatelet antibody (7E3) and murine monoclonal anti-methotrexate IgG (AMI) were grown in serum-free media. Next, 7E3, 8 mg kg<Superscript>−1</Superscript>, was administered intravenously to rats following pretreatment with saline or AMI (1 g kg<Superscript>−1</Superscript> IV). AMI and 7E3 plasma concentrations were determined via enzyme-linked immunosorbent assay, and platelet count was determined with a Cell-Dyne hematology analyzer. Severe, transient thrombocytopenia was induced by 7E3. Platelet counts dropped to ≈8% of initial values within 1 hour after 7E3 administration. AMI pretreatment dramatically affected 7E3-induced thrombocytopenia, significantly altering the time course of throm-bocytopenia (<Emphasis Type="Italic">P</Emphasis>&lt;.05) and significantly decreasing the severity of 7E3-induced thrombocytopenia (ie, following AMI pretreatment, nadir platelet count was greater than 8-fold that of the control group,<Emphasis Type="Italic">P</Emphasis>&lt;.05). In addition, AMI pretreatment induced a 57% increase in 7E3 clearance (1.13±0.13 mL h<Superscript>−1</Superscript> kg<Superscript>−1</Superscript> vs 0.72±0.08 mL h<Superscript>−1</Superscript> kg<Superscript>−1</Superscript>,<Emphasis Type="Italic">P</Emphasis>&lt;.05). Consequently, high-dose monoclonal antibody therapy attenuated thrombocytopenia and produced a moderate increase in the clearance of antiplatelet antibodies in a rat model of ITP.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>Immune thrombocytopenia</Keyword>
              <Keyword>autoimmune</Keyword>
              <Keyword>IVIG</Keyword>
              <Keyword>autoantibody</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: January 13, 2006</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_74895.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JN</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Woolf</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GE</Initials>
                    <FamilyName>Raskob</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Idiopathic throm bocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>88</VolumeID>
                  <FirstPage>3</FirstPage>
                  <LastPage>40</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8704187</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XjvFSnsLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>George JN, Woolf SH, Raskob GE, et al. Idiopathic throm bocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.<Emphasis Type="Italic">Blood.</Emphasis> 1996;88:3–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Imbach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Barandun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>d’Apuzzo</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1981</Year>
                  <ArticleTitle Language="En">High-dose intravenous gammaglobulin for idiopathic throm bocytopenic purpura in childhood</ArticleTitle>
                  <JournalTitle>Lancet.</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>1228</FirstPage>
                  <LastPage>1231</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6112565</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(81)92400-4</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL3M7ps1Cjtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Imbach P, Barandun S, d’Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic throm bocytopenic purpura in childhood.<Emphasis Type="Italic">Lancet.</Emphasis> 1981;1:1228–1231.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Bussel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Hilgartner</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence</ArticleTitle>
                  <JournalTitle>Hematol Oncol Clin North Am.</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>465</FirstPage>
                  <LastPage>482</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2452151</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL1c7pslyqtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bussel JB, Hilgartner MW. Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence.<Emphasis Type="Italic">Hematol Oncol Clin North Am.</Emphasis> 1987;1:465–482.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Adams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DP</Initials>
                    <FamilyName>Nathan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Bennett</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy</ArticleTitle>
                  <JournalTitle>Blood Rev.</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>65</FirstPage>
                  <LastPage>67</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11913999</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1054/blre.2001.0186</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD387otFKlug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Adams JR, Nathan DP, Bennett CL. Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy.<Emphasis Type="Italic">Blood Rev.</Emphasis> 2002;16:65–67.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ED</Initials>
                    <FamilyName>Gomperts</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Gammagard and reported hepatitis C virus episodes</ArticleTitle>
                  <JournalTitle>Clin Ther.</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>3</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8930438</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0149-2918(96)80192-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gomperts ED. Gammagard and reported hepatitis C virus episodes.<Emphasis Type="Italic">Clin Ther.</Emphasis> 1996;18:3–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Milgrom</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Shortage of intravenous immunoglobulin</ArticleTitle>
                  <JournalTitle>Ann Allergy Asthma Immunol.</JournalTitle>
                  <VolumeID>81</VolumeID>
                  <FirstPage>97</FirstPage>
                  <LastPage>100</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9723552</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1czovV2ntw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1081-1206(10)62792-5</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Milgrom H. Shortage of intravenous immunoglobulin.<Emphasis Type="Italic">Ann Allergy Asthma Immunol.</Emphasis> 1998;81:97–100.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Fehr</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Hofmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Kappeler</FamilyName>
                  </BibAuthorName>
                  <Year>1982</Year>
                  <ArticleTitle Language="En">Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-sose intravenous gamma globulin</ArticleTitle>
                  <JournalTitle>N Engl J Med.</JournalTitle>
                  <VolumeID>306</VolumeID>
                  <FirstPage>1254</FirstPage>
                  <LastPage>1258</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6803159</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL387ntlSltQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJM198205273062102</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-sose intravenous gamma globulin.<Emphasis Type="Italic">N Engl J Med.</Emphasis> 1982;306:1254–1258.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balthasar</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>2087</FirstPage>
                  <LastPage>2093</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12200371</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xnt1yhs7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hansen RJ, Balthasar JP. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.<Emphasis Type="Italic">Blood.</Emphasis> 2002;100:2087–2093.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Berchtold</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>Dale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Tani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>McMillan</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by antiidiotypic antibodies in intravenous gammaglobulin</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>2414</FirstPage>
                  <LastPage>2417</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2478230</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3c%2FivVOrsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Berchtold P, Dale GL, Tani P, McMillan R. Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by antiidiotypic antibodies in intravenous gammaglobulin.<Emphasis Type="Italic">Blood.</Emphasis> 1989;74:2414–2417.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Salama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Mueller-Eckhardt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Kiefel</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ArticleTitle Language="En">Effect of intravenous immunoglobulin in immune thrombocytopenia</ArticleTitle>
                  <JournalTitle>Lancet.</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>193</FirstPage>
                  <LastPage>195</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6135031</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(83)90175-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL3s3ktlKntQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia.<Emphasis Type="Italic">Lancet.</Emphasis> 1983;2:193–195.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ballow</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases</ArticleTitle>
                  <JournalTitle>J Allergy Clin Immunol.</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>151</FirstPage>
                  <LastPage>157</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9275133</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0091-6749(97)70217-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2svhvFSmtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases.<Emphasis Type="Italic">J Allergy Clin Immunol.</Emphasis> 1997;100:151–157.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Tovo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Miniero</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Fiandino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Saracco</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Messina</FamilyName>
                  </BibAuthorName>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Fc-depleted vs intact intravenous immunoglobulin in chronic ITP</ArticleTitle>
                  <JournalTitle>J Pediatr.</JournalTitle>
                  <VolumeID>105</VolumeID>
                  <FirstPage>676</FirstPage>
                  <LastPage>677</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6207282</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL2M%2FgvFWntA%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1016/S0022-3476(84)80455-2</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Tovo PA, Miniero R, Fiandino G, Saracco P, Messina M. Fc-depleted vs intact intravenous immunoglobulin in chronic ITP.<Emphasis Type="Italic">J Pediatr.</Emphasis> 1984;105:676–677.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Debre</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Bonnet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WH</Initials>
                    <FamilyName>Fridman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura</ArticleTitle>
                  <JournalTitle>Lancet.</JournalTitle>
                  <VolumeID>342</VolumeID>
                  <FirstPage>945</FirstPage>
                  <LastPage>949</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8105212</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0140-6736(93)92000-J</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c%2FhvVWmsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Debre M, Bonnet MC, Fridman WH, et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura.<Emphasis Type="Italic">Lancet.</Emphasis> 1993;342:945–949.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ED</Initials>
                    <FamilyName>Lobo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Soda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balthasar</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Application of pharmacokineticpharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice</ArticleTitle>
                  <JournalTitle>J Pharm Sci.</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>1665</FirstPage>
                  <LastPage>1676</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12884253</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jps.10432</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmtFektrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lobo ED, Soda DM, Balthasar JP. Application of pharmacokineticpharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice.<Emphasis Type="Italic">J Pharm Sci.</Emphasis> 2003;92:1665–1676.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balthasar</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>298</VolumeID>
                  <FirstPage>165</FirstPage>
                  <LastPage>171</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11408538</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXksFChtb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hansen RJ, Balthasar JP. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2001;298:165–171.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ZR</Initials>
                    <FamilyName>Tayab</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balthasar</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Development and validation of enzymelinked immunosorbent assay for quantification of anti-methotrexate IgG and Fab in mouse and rat plasma</ArticleTitle>
                  <JournalTitle>J Immunoassay Immunochem.</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>335</FirstPage>
                  <LastPage>344</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15552588</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXosFShsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tayab ZR, Balthasar JP. Development and validation of enzymelinked immunosorbent assay for quantification of anti-methotrexate IgG and Fab in mouse and rat plasma.<Emphasis Type="Italic">J Immunoassay Immunochem.</Emphasis> 2004;25:335–344.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WJ</Initials>
                    <FamilyName>Harrington</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Minnich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Hollingsworth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CV</Initials>
                    <FamilyName>Moore</FamilyName>
                  </BibAuthorName>
                  <Year>1951</Year>
                  <ArticleTitle Language="En">Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura</ArticleTitle>
                  <JournalTitle>J Lab Clin Med.</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>10</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14850832</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaG38XmtlGg</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura.<Emphasis Type="Italic">J Lab Clin Med.</Emphasis> 1951;38:1–10.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>NR</Initials>
                    <FamilyName>Shulman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VJ</Initials>
                    <FamilyName>Marder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RS</Initials>
                    <FamilyName>Weinrach</FamilyName>
                  </BibAuthorName>
                  <Year>1965</Year>
                  <ArticleTitle Language="En">Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic and isotopic studies</ArticleTitle>
                  <JournalTitle>Ann N Y Acad Sci.</JournalTitle>
                  <VolumeID>124</VolumeID>
                  <FirstPage>499</FirstPage>
                  <LastPage>542</LastPage>
                  <Occurrence Type="PID">
                    <Handle>5214832</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1749-6632.1965.tb18984.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaF2MXks1Gku74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic and isotopic studies.<Emphasis Type="Italic">Ann N Y Acad Sci.</Emphasis> 1965;124:499–542.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EF</Initials>
                    <FamilyName>Leeuwen</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JT</Initials>
                    <FamilyName>Ven</FamilyName>
                    <Particle>van der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Engelfriet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Borne</FamilyName>
                    <Particle>von dem</Particle>
                  </BibAuthorName>
                  <Year>1982</Year>
                  <ArticleTitle Language="En">Specificity of autoantibodies in autoimmune thrombocytopenia</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>23</FirstPage>
                  <LastPage>26</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7032627</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE. Specificity of autoantibodies in autoimmune thrombocytopenia.<Emphasis Type="Italic">Blood.</Emphasis> 1982;59:23–26.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VL</Initials>
                    <FamilyName>Woods</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kurata</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RR</Initials>
                    <FamilyName>Montgomery</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>156</FirstPage>
                  <LastPage>160</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6234034</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Woods VL Jr, Kurata Y, Montgomery RR, et al. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura.<Emphasis Type="Italic">Blood.</Emphasis> 1984;64:156–160.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Fujisawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Tani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>McMillan</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>81</VolumeID>
                  <FirstPage>1284</FirstPage>
                  <LastPage>1289</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7680243</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3s7osVehsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fujisawa K, Tani P, McMillan R. Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens.<Emphasis Type="Italic">Blood</Emphasis>. 1993;81:1284–1289.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Stockelberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kutti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Wadenvik</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies</ArticleTitle>
                  <JournalTitle>Br J Haematol.</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>64</FirstPage>
                  <LastPage>67</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9233565</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1365-2141.1997.1883006.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXltlWltLY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hou M, Stockelberg D, Kutti J, Wadenvik H. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies.<Emphasis Type="Italic">Br J Haematol.</Emphasis> 1997;98:64–67.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HW</Initials>
                    <FamilyName>Snyder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Cochran</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balint</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Experience with protein A-immunoadsorption in treatment-resistant adult immune throm bocytopenic purpura</ArticleTitle>
                  <JournalTitle>Blood.</JournalTitle>
                  <VolumeID>79</VolumeID>
                  <FirstPage>2237</FirstPage>
                  <LastPage>2245</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1571540</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Snyder HW, Jr, Cochran SK Jr, Balint JP Jr, et al. Experience with protein A-immunoadsorption in treatment-resistant adult immune throm bocytopenic purpura.<Emphasis Type="Italic">Blood.</Emphasis> 1992;79:2237–2245.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TH</Initials>
                    <FamilyName>Guthrie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Oral</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Immune thrombocytopenia purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients</ArticleTitle>
                  <JournalTitle>Semin Hamatol.</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <FirstPage>3</FirstPage>
                  <LastPage>9</LastPage>
                </BibArticle>
                <BibUnstructured>Guthrie TH Jr, Oral A. Immune thrombocytopenia purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients.<Emphasis Type="Italic">Semin Hamatol.</Emphasis> 1989;26:3–9.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FW</Initials>
                    <FamilyName>Brambell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Hemmings</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IG</Initials>
                    <FamilyName>Morris</FamilyName>
                  </BibAuthorName>
                  <Year>1964</Year>
                  <ArticleTitle Language="En">A theoretical model of gamma-globulin catabolism</ArticleTitle>
                  <JournalTitle>Nature.</JournalTitle>
                  <VolumeID>203</VolumeID>
                  <FirstPage>1352</FirstPage>
                  <LastPage>1354</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14207307</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/2031352a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaF2M%2FhtFKruw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brambell FW, Hemmings WA, Morris IG. A theoretical model of gamma-globulin catabolism.<Emphasis Type="Italic">Nature.</Emphasis> 1964;203:1352–1354.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>Jones</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TA</Initials>
                    <FamilyName>Waldmann</FamilyName>
                  </BibAuthorName>
                  <Year>1972</Year>
                  <ArticleTitle Language="En">The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat</ArticleTitle>
                  <JournalTitle>J Clin Invest.</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>2916</FirstPage>
                  <LastPage>2927</LastPage>
                  <Occurrence Type="PID">
                    <Handle>5080417</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI107116</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE38Xls1aqsb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jones EA, Waldmann TA. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat.<Emphasis Type="Italic">J Clin Invest.</Emphasis> 1972;51:2916–2927.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>NE</Initials>
                    <FamilyName>Simister</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Mostov</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">An Fc receptor structurally related to MHC class I antigens</ArticleTitle>
                  <JournalTitle>Nature.</JournalTitle>
                  <VolumeID>337</VolumeID>
                  <FirstPage>184</FirstPage>
                  <LastPage>187</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2911353</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/337184a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXltFegtr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Simister NE, Mostov KE. An Fc receptor structurally related to MHC class I antigens.<Emphasis Type="Italic">Nature.</Emphasis> 1989;337:184–187.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Israel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DF</Initials>
                    <FamilyName>Wilsker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Hayes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Schoenfeld</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NE</Initials>
                    <FamilyName>Simister</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn</ArticleTitle>
                  <JournalTitle>Immunology</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>573</FirstPage>
                  <LastPage>578</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9014824</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1365-2567.1996.d01-775.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXlsV2m</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Israel EJ, Wilsker DF, Hayes KC, Schoenfeld D, Simister NE. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn.<Emphasis Type="Italic">Immunology</Emphasis>. 1996;89:573–578.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Ghetie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Hubbard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JK</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MF</Initials>
                    <FamilyName>Tsen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ES</Initials>
                    <FamilyName>Ward</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Abnormally short serum half-lives of IgG in beta 2-microglobulindeficient mice</ArticleTitle>
                  <JournalTitle>Eur J Immunol.</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <FirstPage>690</FirstPage>
                  <LastPage>696</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8605939</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.1830260327</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvVGntLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in beta 2-microglobulindeficient mice.<Emphasis Type="Italic">Eur J Immunol.</Emphasis> 1996;26:690–696.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RP</Initials>
                    <FamilyName>Junghans</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA.</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <FirstPage>5512</FirstPage>
                  <LastPage>5516</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8643606</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.93.11.5512</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xjt1Ojsb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 1996;93:5512–5516.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balthasar</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor</ArticleTitle>
                  <JournalTitle>Thromb Haemost.</JournalTitle>
                  <VolumeID>88</VolumeID>
                  <FirstPage>898</FirstPage>
                  <LastPage>899</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12529736</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXisVWhtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hansen RJ, Balthasar JP. Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.<Emphasis Type="Italic">Thromb Haemost.</Emphasis> 2002;88:898–899.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balthasar</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia</ArticleTitle>
                  <JournalTitle>J Pharm Sci.</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <FirstPage>1206</FirstPage>
                  <LastPage>1215</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12761810</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jps.10364</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXks1KisLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hansen RJ, Balthasar JP. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.<Emphasis Type="Italic">J Pharm Sci.</Emphasis> 2003;92:1206–1215.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Bussel</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Another interaction of the FcR system with IVIG</ArticleTitle>
                  <JournalTitle>Thromb Haemost.</JournalTitle>
                  <VolumeID>88</VolumeID>
                  <FirstPage>890</FirstPage>
                  <LastPage>891</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12529734</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXisVWhtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bussel JB. Another interaction of the FcR system with IVIG.<Emphasis Type="Italic">Thromb Haemost.</Emphasis> 2002;88:890–891.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>Vaughn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Bjorkman</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization</ArticleTitle>
                  <JournalTitle>Biochemistry.</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>9374</FirstPage>
                  <LastPage>9380</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9235980</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/bi970841r</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXkslelu74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vaughn DE, Bjorkman PJ. High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization.<Emphasis Type="Italic">Biochemistry.</Emphasis> 1997;36:9374–9380.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ED</Initials>
                    <FamilyName>Lobo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Hansen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Balthasar</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Antibody pharmacokinetics and pharmacodynamics</ArticleTitle>
                  <JournalTitle>J Pharm Sci.</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <FirstPage>2645</FirstPage>
                  <LastPage>2668</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15389672</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jps.20178</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXpvV2isLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetics and pharmacodynamics.<Emphasis Type="Italic">J Pharm Sci.</Emphasis> 2004;93:2645–2668.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
